#USA #LabConnect #Johnson City #AI Solution #OmniScience

LabConnect and OmniScience Unveil Revolutionary AI Solution

In a groundbreaking collaboration, LabConnect, a renowned global provider of central laboratory services, has announced a strategic partnership with OmniScience, a leader in AI technology. This partnership aims to deliver the first-ever AI-driven solution for obtaining real-time insights from clinical trial laboratory data. As clinical trial processes become increasingly complex, the integration of AI technology is poised to revolutionize the landscape of laboratory data management and decision-making.

Overcoming Challenges with AI Integration

Traditional clinical trial laboratory data is often isolated, complicated, and sluggish in response time. This can hinder prompt decision-making and introduce various risks into the trial process. LabConnect plans to combine its extensive experience in centralized laboratory analysis and data management with OmniScience's innovative Vivo platform. This collaboration is set to unify fragmented laboratory datasets, automate oversight processes, and identify risk signals. Ultimately, this synergy aims to accelerate trial timelines while enhancing overall trial outcomes.

Introducing Vivo

Vivo, OmniScience's next-generation AI-powered platform, is specifically designed to transform team interactions with clinical data throughout the development lifecycle. This unique platform serves as a control tower, offering real-time insights by integrating disparate information sources and providing clarity to clinical, operational, safety, and data science teams. The specialized implementation of Vivo known as Vivo-Lab applies these intelligent insights directly to laboratory data. It enhances laboratory workflows by revealing critical trends, anomalies, and discrepancies as they arise, allowing teams to transition from reactive to proactive monitoring in one of the most dynamic aspects of clinical research.

Voices from Leadership

Angela Holmes, the CEO and co-founder of OmniScience, expressed her enthusiasm about the collaboration: "Our mission at OmniScience is to enable clinical trial teams to visualize and act faster. Partnering with LabConnect brings that vision to life by converting laboratory data into actionable real-time insights that sponsors can trust."

Meanwhile, Wes Wheeler, CEO of LabConnect, emphasized the transformative power of this partnership: "At LabConnect, we are committed to helping sponsors unlock the full potential of their laboratory data. Integrating OmniScience's cutting-edge AI technology transforms static laboratory report outputs into dynamic, actionable information. Together, we equip clinical operations teams with the speed, agility, and precision required for smarter decision-making, enhancing clinical trial efficiency and expediting patient access to innovative therapies."

This strategic alliance underlines both organizations' dedication to fostering innovation in clinical development, brilliantly merging LabConnect's technology-driven laboratory operations with OmniScience's native AI approach towards clinical intelligence.

What Makes LabConnect Stand Out

LabConnect, LLC stands as a principal provider of integrated laboratory services, FSP consultancy, and complex analytical and logistical data transformation services tailored for fields such as immuno-oncology, cellular and gene therapies, as well as rare and orphan diseases. Leveraging cutting-edge technology, premier laboratories, and a wealth of expertise in specialized testing, LabConnect instills confidence in pharmaceutical development companies by serving as a sole provider for their central laboratory service needs. For more detailed information, visit LabConnect and follow them on LinkedIn.

About OmniScience

OmniScience is at the forefront of AI-driven clinical development solutions, boasting Vivo as the first AI control tower tailored explicitly for clinical trials. The platform is developed by a skilled team of clinical data scientists, enabling the unification of fragmented trial data, intelligent automation, and delivering explainable real-time insights that assist sponsors in trimming costs, shortening timelines, and enhancing success rates. Recognized by various prestigious programs such as Johnson & Johnson's JLABS, NVIDIA Inception, and Google Cloud for AI, OmniScience is a trailblazer in ushering in a new era of clinical trial intelligence, ultimately accelerating the delivery of life-saving treatments to patients.